Stefan Laufer
- Molecular Biology top 0.5%
- Organic Chemistry top 0.2%
- Pharmacology top 0.2%
- Oncology top 1%
- Physiology top 1%
- Co-authors
- Matthias GehringerFlorian LängPierre KochCaterina FaggioGerd K. WagnerMeinrad GawazOliver BorstEvi Schmid
- Topics
- Melanoma and MAPK Pathways (113 papers)Synthesis and biological activity (101 papers)Inflammatory mediators and NSAID effects (47 papers)
- Journals
- Proceedings of the National Academy of SciencesThe LancetJournal of the American Chemical Society
- Partner nations
- GermanyBrazilUnited States
In The Last Decade
Stefan Laufer
455 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Molecular Biology 6.8k
- Organic Chemistry 4.0k
- Pharmacology 2.2k
- Oncology 1.8k
- Physiology 1.5k
Countries citing papers authored by Stefan Laufer
This map shows the geographic impact of Stefan Laufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Laufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Laufer more than expected).
Fields of papers citing papers by Stefan Laufer
This network shows the impact of papers produced by Stefan Laufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Laufer. The network helps show where Stefan Laufer may publish in the future.
Co-authorship network of co-authors of Stefan Laufer
This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Laufer. A scholar is included among the top collaborators of Stefan Laufer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Laufer. Stefan Laufer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 14 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 4 | |
| 14 | 40 | |
| 15 | 23 | |
| 16 | 20 | |
| 17 | 19 | |
| 18 | 30 | |
| 19 | Targeting Cancer Stem Cells with Defined Compounds and Drugs | 16 |
| 20 | Acute and chronic anti-inflammatory properties of [2,2-dimethyl-6-(4- chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid. | 25 |
About Stefan Laufer
Stefan Laufer is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology, having authored 469 papers that have together received 15.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (113 papers), Synthesis and biological activity (101 papers) and Inflammatory mediators and NSAID effects (47 papers). The work is most often cited by research in Organic Chemistry (4.0k citations), Pharmacology (2.2k citations) and Molecular Biology (6.8k citations). Stefan Laufer has collaborated with scholars based in Germany, Brazil and United States. Frequent co-authors include Matthias Gehringer, Florian Läng, Pierre Koch, Caterina Faggio, Gerd K. Wagner, Meinrad Gawaz, Oliver Borst, Evi Schmid, Patrick Münzer and Britta Walker. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.